Literature DB >> 30233166

Prevalence of undiagnosed COPD in male patients with coronary artery disease: a cross-sectional study in Jordan.

Basheer Y Khassawneh1, Shaher M Samrah1, Mohamad I Jarrah1, Rasheed K Ibdah1, Ali M Ibnian1, Abdel-Hameed W Al-Mistarehi1, Aseel A Zghayer1, Saddam I Abuqudairi1, Yousef S Khader2.   

Abstract

Purpose: COPD and coronary artery disease (CAD) are common chronic diseases with shared risk factors. COPD continues to be largely underdiagnosed and undertreated. We aimed to describe the prevalence and predictors of undiagnosed COPD in Jordanian men with CAD. Patients and methods: In a cross-sectional study conducted at a referral center in Jordan, male patients who underwent coronary angiography for suspected CAD and reported ≥10 pack-year of cigarette smoking were recruited. Pre- and post-bronchodilator spirometry was undertaken for all participants, and COPD was defined as post-bronchodilator FEV1/FVC <70%. The finding of ≥50% coronary luminal narrowing confirmed the presence of CAD.
Results: Spirometry was undertaken for 376 men with mean age of 56.02±10.55 years, and 72.6% were active cigarettes smokers with a mean pack-year of 55.89±34.25. A CAD diagnosis was confirmed in 300 (79.8%) men. Spirometric criteria for COPD were met in 76 (15.7%) patients, of whom 91.5% were not previously diagnosed. COPD-related symptoms were common: chronic cough (44.4%), dyspnea (66.2%), and wheezes (27.9%). COPD was more common in patients with (18.0%) compared to patients without (6.6%) CAD (P=0.014). Multivariate logistic regression showed that the risk of COPD was higher in patients with CAD (OR 3.16, 95% CI, 1.10-9.09, P=0.033) and in those with chronic bronchitis (OR 13.07, 95% CI, 6.69-25.52, P<0.001).
Conclusion: There was a high prevalence of COPD among male patients with CAD and most were underdiagnosed despite having respiratory symptoms. Male smokers with CAD and respiratory symptoms should be evaluated for airflow limitation and the presence of COPD.
© 2018 Khassawneh et al.

Entities:  

Keywords:  COPD; airflow limitation; cardiovascular disease; coronary catheterization; spirometry

Year:  2018        PMID: 30233166      PMCID: PMC6130534          DOI: 10.2147/COPD.S172679

Source DB:  PubMed          Journal:  Int J Chron Obstruct Pulmon Dis        ISSN: 1176-9106


  5 in total

1.  Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study.

Authors:  Komal Malik; Susana Diaz-Coto; Maria de la Asunción Villaverde; Pablo Martinez-Camblor; Annie Navarro-Rolon; Francisco Pujalte; Alejandro De la Sierra; Pere Almagro
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-10-14

2.  Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis.

Authors:  Lingling Xuan; Feifei Han; Lili Gong; Yali Lv; Zirui Wan; He Liu; Dongsu Zhang; Yangjie Jia; Song Yang; Lulu Ren; Lihong Liu
Journal:  Lipids Health Dis       Date:  2018-11-21       Impact factor: 3.876

3.  The Burden of Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases: A Non-Western Perspective.

Authors:  Kartik Deshmukh; Arjun Khanna
Journal:  Tuberc Respir Dis (Seoul)       Date:  2021-02-17

4.  Chronic obstructive pulmonary disease patients' quality of life and its related factors: A cross-sectional study of the Jordanian population.

Authors:  Enas A Assaf; Angham Badarneh; Ahmad Saifan; Nabeel Al-Yateem
Journal:  F1000Res       Date:  2022-05-26

5.  Plasma Concentrations of Vinculin versus Talin-1 in Coronary Artery Disease.

Authors:  Masayuki Aoyama; Yoshimi Kishimoto; Emi Saita; Reiko Ohmori; Kojiro Tanimoto; Masato Nakamura; Kazuo Kondo; Yukihiko Momiyama
Journal:  Med Sci (Basel)       Date:  2022-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.